APA (7th ed.) Citation

MR, T., JR, A., JR, P., MS, I., MA, A., NR, P., . . . T, C. (2025). Outcomes for Patients Aged 12-18 Months With Metastatic MYCN Non-Amplified Neuroblastoma and Unfavorable Biologic Features ("Mixed Biology Toddlers"): A Report From the International Neuroblastoma Risk Group (INRG) Project. Pediatric blood & cancer, 72(11), e31968. https://doi.org/10.1002/pbc.31968

Chicago Style (17th ed.) Citation

MR, Taylor, et al. "Outcomes for Patients Aged 12-18 Months With Metastatic MYCN Non-Amplified Neuroblastoma and Unfavorable Biologic Features ("Mixed Biology Toddlers"): A Report From the International Neuroblastoma Risk Group (INRG) Project." Pediatric Blood & Cancer 72, no. 11 (2025): e31968. https://doi.org/10.1002/pbc.31968.

MLA (9th ed.) Citation

MR, Taylor, et al. "Outcomes for Patients Aged 12-18 Months With Metastatic MYCN Non-Amplified Neuroblastoma and Unfavorable Biologic Features ("Mixed Biology Toddlers"): A Report From the International Neuroblastoma Risk Group (INRG) Project." Pediatric Blood & Cancer, vol. 72, no. 11, 2025, p. e31968, https://doi.org/10.1002/pbc.31968.